title: HGF converts ErbB2/Neu epithelial morphogenesis to cell invasion.
abstract: Activation of the hepatocyte growth factor receptor Met induces a morphogenic response and stimulates the formation of branching tubules by Madin-Darby canine kidney (MDCK) epithelial cells in three-dimensional cultures. A constitutively activated ErbB2/Neu receptor, NeuNT, promotes a similar invasive morphogenic program in MDCK cells. Because both receptors are expressed in breast epithelia, are associated with poor prognosis, and hepatocyte growth factor (HGF) is expressed in stroma, we examined the consequence of cooperation between these signals. We show that HGF disrupts NeuNT-induced epithelial morphogenesis, stimulating the breakdown of cell-cell junctions, dispersal, and invasion of single cells. This correlates with a decrease in junctional proteins claudin-1 and E-cadherin, in addition to the internalization of the tight junction protein ZO-1. HGF-induced invasion of NT-expressing cells is abrogated by pretreatment with a pharmacological inhibitor of the mitogen-activated protein kinase kinase (MEK) pathway, which restores E-cadherin and ZO-1 at cell-cell junctions, establishing the involvement of MEK-dependent pathways in this process. These results demonstrate that physiological signals downstream from the HGF/Met receptor synergize with ErbB2/Neu to enhance the malignant phenotype, promoting the breakdown of cell-cell junctions and enhanced cell invasion. This is particularly important for cancers where ErbB2/Neu is overexpressed and HGF is a physiological growth factor found in the stroma.
authors.affiliation: Molecular Oncology Group, McGill University Health Center, McGill University, Montreal, Quebec, H3A 1A1, Canada.
authors.forename: Hanane
authors.initials: H
authors.lastname: Khoury
authors.forename: Monica A
authors.initials: MA
authors.lastname: Naujokas
authors.forename: Dongmei
authors.initials: D
authors.lastname: Zuo
authors.forename: Veena
authors.initials: V
authors.lastname: Sangwan
authors.forename: Melanie M
authors.initials: MM
authors.lastname: Frigault
authors.forename: Stephanie
authors.initials: S
authors.lastname: Petkiewicz
authors.forename: David L
authors.initials: DL
authors.lastname: Dankort
authors.forename: William J
authors.initials: WJ
authors.lastname: Muller
authors.forename: Morag
authors.initials: M
authors.lastname: Park
mesh_terms: D000818:Animals; D023102:Anoikis; D015153:Blotting, Western; D015820:Cadherins / Q000378:metabolism; D002460:Cell Line; D002465:Cell Movement; D062445:Claudin-1; D003094:Collagen / Q000378:metabolism; D004285:Dogs; D004338:Drug Combinations; D004847:Epithelial Cells / Q000166:cytology*; D005109:Extracellular Matrix / Q000378:metabolism; D018734:Genes, erbB-2; D017228:Hepatocyte Growth Factor / Q000378:metabolism*; D007797:Laminin / Q000378:metabolism; D008565:Membrane Proteins / Q000378:metabolism; D018613:Microscopy, Confocal; D008954:Models, Biological; D009024:Morphogenesis; D010750:Phosphoproteins / Q000378:metabolism; D011233:Precipitin Tests; D011509:Proteoglycans / Q000378:metabolism; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D019108:Tight Junctions; D062826:Zonula Occludens-1 Protein
chemical_list: D015820:Cadherins; D062445:Claudin-1; D003094:Collagen; D004338:Drug Combinations; D017228:Hepatocyte Growth Factor; D007797:Laminin; D008565:Membrane Proteins; D010750:Phosphoproteins; D011509:Proteoglycans; D018719:Erb-b2 Receptor Tyrosine Kinases; D062826:Zonula Occludens-1 Protein; C059485:matrigel